First published 10/3/2026, 2:03:15 PM · Last updated 10/3/2026, 2:03:30 PM

Grapefruit-derived nanovesicles: a promising nanoplatform for enhancing the therapeutic efficacy of andrographolide against ulcerative colitis

A journal article reports development of grapefruit-derived nanovesicles intended to improve delivery and therapeutic efficacy of andrographolide for ulcerative colitis. Publisher is listed as Elsevier BV and the item is a journal article published 2026-11-01.

Illustrative image: STS-41 MS Akers rehydrates a grapefruit drink at OV-103's middeck galley — NASA/JSC/NASA Image and Video Library, NASA Media Usage Guidelines

Categories: science-and-space, public-health

Generated scores

Scores are based on the cited reporting and use a 1–10 scale. Read the methodology.

Confidence: 6/10How certain the assessment is based on the clarity and evidence in the cited reporting.
Geographic reach: 1/10How widely the event reaches, from a local area (1) to worldwide impact (10).
Global importance: 3/10The event's broader significance, from limited importance (1) to major global importance (10).
Impact magnitude: 3/10The scale or severity of the real-world impact, from minor (1) to extreme (10).
Positivity: 7/10How harmful or beneficial the event is, from strongly harmful (1) to strongly positive (10).
Urgency: 2/10How time-sensitive the event is, from low urgency (1) to immediate attention needed (10).

Why it matters

The paper describes a potential new delivery approach for a treatment against ulcerative colitis.

Sources

Grapefruit-derived nanovesicles: a promising nanoplatform for enhancing the therapeutic efficacy of andrographolide against ulcerative colitis

Report an issue